866-997-4948(US-Canada Toll Free)

Nanotechnology for Drug Delivery : Global Market for Nanocarriers

Published By :

Cientifica

Published Date : Feb 2012

Category :

Nanotechnology

No. of Pages : 108 Pages

 

Nanocarriers will account for 40% of a $136 billion nanotechnology-enabled drug delivery market by 2021. We forecast the total market size in 2021 to be US$136 billion, with a 60/40 split between nanocrystals and nanocarriers respectively, although developing new targeted delivery mechanisms may allow more value to be created for companies and entrepreneurs.

 

Of the 10 nanocarrier technologies studied, liposomes and gold nanocarriers account for 45% of the total addressable market. Liposomes will offer the largest addressable market ($15 billion) in 2021 while gold nanocarriers will see the highest compound annual growth rate (CAGR)—53.8%—in the next decade.

 

Drugs are loaded into nanocarriers (also called nanoshells or nanoparticles, between 1 and 100 nm), then transported through the body to the target site. This kind of targeted drug delivery for the treatment of cancers is one of the most anticipated and discussed benefits of nanotechnology-enabled medicine as it offers a level of accuracy in delivering drugs that far surpasses present methods. Typically over 90% of a drug is wasted in the body, which leads to unwanted side effects. Modern chemotherapy  bombards patients with drugs in the hope that tumorous cells will be destroyed. The lack of specificity of current drug delivery techniques mean patients’ healthy cells are destroyed indiscriminately along with cancer cells.

 

Using nanotechnology to combat cancer is not new. Abraxane, the first nanoparticulate drug delivery product for the treatment of breast cancer, launched six years ago. There are now hundreds of new nanotech-based treatments under development, ranging from reformulation of existing drugs to enhance their efficacy to radical new “magic bullet” therapies.

 

The healthcare market is changing. We are seeing a paradigm shift away from blockbusters and a ‘one-size fits all’ approach to a more personalised medicine based on an individual’s unique genome and immune response. The more scientists learn about the molecular causes for disease the more targeted and effective nanotechnology-enabled drug delivery therapies will become.

Table of Contents

Executive Summary

Chapter 1

Report Scope
Thematic Scope
Scope of Data Analysis
Temporal Scope of Analysis
Geographical Scope
Report objective
Methodology
Calculation of CAGR
The Nanoscale

Chapter 2
Overview of nanotechnology
What are the Key Drivers for Adoption of Nanotechnology in Medicine and Biomedicine?
The Key Applications of Nanotechnology in Medicine and Biomedicine
How Nanotechnology Can Benefit Drug Delivery
How Nanotechnology Is Already Having An Impact On The Drug Delivery Sector

Chapter 3
Three Key Barriers to The Adoption of Nanotechnology in Medicine and Biomedicine
Five Current & Future Challenges in The Adoption of Nanotechnology in Medicine and Biomedicine

Chapter 4
Global Market Analysis: 2000-2010 (Without Segmentation)
Global Market Forecast: 2011-2021 (Without Segmentation)
Market Analysis Countries and Regions: 2000-2010 (With Segmentation)
Market Forecast Countries and Regions: 2011-2021 (With Segmentation)

Appendix
Publishing activity by organization (2000-2010)

List of Table

Chapter One

Exhibit 1.1


Formula for the calculation of the Compound Annual Growth Rate (CAGR), (top).

Formula for the calculation of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.2

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR), (top).

Formula for the verification of the calculated values of the Compound Annual Growth Rate (CAGR) in this report, for the 2011-2021 period, (bottom) [2].

Exhibit 1.3

Nanometres in a meter (top). Meters in a nanometre (bottom).

Chapter Two

Exhibit 2.1


The periodic table of elements, as we know it (at meter scale) is governed by classic Newtonian laws of physics. However, when perceived at nanoscale, those elements are governed by the laws of quantum physics.

Exhibit 2.2

Proportion of the population aged over 65 and over 80 [7].

Exhibit 2.3

Illustration of a diagram of each property of nanocarriers (size, shape, surface chemistry and mechanical properties) and their parameters subjected to optimization in order to improve their efficiency [10].

Chapter Three

Exhibit 3.1


Specified expected barriers in the development of particular types of nanoparticles (Courtesy of CienNanoroadmap Synthesis Report), [6].

Exhibit 3.2

Illustration of the measures adoption roadmap to combat/attenuate the key barriers to the adoption of nanotechnology in medicine and biomedicine (Source: Cientifica, Ltd.).

Exhibit 3.3

Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.4

Line chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.5

Bar chart representing Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.6

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.7

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Exhibit 3.8

Bar chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, without segmentation, source: Cientifica (all figures US$ Million Dollars).

Chapter Four:

Exhibit 4.8


Table representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, all countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.9

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures in percentage).

Exhibit 4.10

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.11

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.12

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.13

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, by world regions and countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.14

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.15

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, all world regions and countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.16

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage)

Exhibit 4.17

Horizontal bar graph representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.18

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.19

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.20

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.21

3-D pie chart representing the Total Addressable Market, TAM in 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.22

Horizontal bar graph representing the Total Addressable Market, TAM In 2010, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.23

Line chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.24

3-D stacked vertical bar graph representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.25

3-D stacked area chart representing the Total Addressable Market, TAM (2000-2010), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.46

Table representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions / countries, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.47

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures in percentage).

Exhibit 4.48

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.49

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.50

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.51

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by world regions, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.52

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.53

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.54

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.55

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.56

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, by all world regions / countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.57

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.58

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.59

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.60

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.61

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, European Union countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.62

3-D pie chart representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures in percentage).

Exhibit 4.63

Horizontal bar graph representing the Total Addressable Market, TAM forecast in 2021, for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.64

Line chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.65

3-D stacked vertical bar graph representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Exhibit 4.66

3-D stacked area chart representing the Total Addressable Market, TAM forecast by 2021 (for the 2011-2021 period), for nanotechnology in drug delivery, Asian countries studied, source: Cientifica (all figures US$ Million Dollars).

Appendix

Exhibit A.1


Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: North America; country: USA.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.2

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: Germany.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.3

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: France.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.4

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: European Union; country: UK.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.5

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Country: Russian Federation.

Organizations are ordered alphabetically (increasing order).

Exhibit A.6

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.7

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: India.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.8

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: Japan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.9

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: P R China.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.10

Table of the top 20 organizations showing the highest publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. World Region: Asia; country: South Korea (Republic of Korea).

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Exhibit A.11

Table of publishing activity in PubMed periodicals (2000-2010), based on PubMed, for Nanotechnology in Drug Delivery. Asia; country: Taiwan.

Organizations are ordered first by descending order of total articles published and then ordered alphabetically (increasing order), if applicable.

Make an enquiry before buying this Report

Please fill the enquiry form below.

  • Full Name *
  • Your Email *
  • Job Title *
  • Company *
  • Phone No. * (Pls. Affix Country Code)
  • Message
  • Security Code *